![SABCS 2022 Conference Coverage](http://media.vumedi.com/thumbs/channel_logo/2022/12/fafc1095-3cea-49d9-83af-227ff115386c.png.200x0_q85.png)
SABCS 2022 Conference Coverage
SABCS 2022 Dose-Expansion Study DESTINY-Breast07: T-DXd as Monotherapy or Combined With Pertuzumab in Patients With Metastatic HER2+ BC
By
SABCS 2022 Conference Coverage
FEATURING
Erika Hamilton
By
SABCS 2022 Conference Coverage
FEATURING
Erika Hamilton
177 views
December 22, 2022
Comments 0
Login to view comments.
Click here to Login
Videos